Bausch Health Cos., Inc. (BHC)
6.415
+0.10
(+1.50%)
USD |
NYSE |
Oct 20, 16:00
6.415
0.00 (0.00%)
After-Hours: 20:00
Bausch Health Cos. Net Income (Quarterly) : 260.00M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 260.00M |
| March 31, 2026 | -1.431B |
| December 31, 2025 | -103.00M |
| September 30, 2025 | 181.00M |
| June 30, 2025 | 128.00M |
| March 31, 2025 | -86.00M |
| December 31, 2024 | 98.00M |
| September 30, 2024 | -92.00M |
| June 30, 2024 | -1.00M |
| March 31, 2024 | -77.00M |
| December 31, 2023 | -47.00M |
| September 30, 2023 | -382.00M |
| June 30, 2023 | 27.00M |
| March 31, 2023 | -209.00M |
| December 31, 2022 | -410.00M |
| September 30, 2022 | 403.00M |
| June 30, 2022 | -139.00M |
| March 31, 2022 | -66.00M |
| December 31, 2021 | 72.00M |
| September 30, 2021 | 191.00M |
| June 30, 2021 | -593.00M |
| March 31, 2021 | -607.00M |
| December 31, 2020 | -152.00M |
| September 30, 2020 | 70.00M |
| June 30, 2020 | -325.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -152.00M |
| December 31, 2019 | -1.517B |
| September 30, 2019 | -48.00M |
| June 30, 2019 | -170.00M |
| March 31, 2019 | -48.00M |
| December 31, 2018 | -342.00M |
| September 30, 2018 | -351.00M |
| June 30, 2018 | -872.00M |
| March 31, 2018 | -2.579B |
| December 31, 2017 | 512.00M |
| September 30, 2017 | 1.30B |
| June 30, 2017 | -37.00M |
| March 31, 2017 | 629.00M |
| December 31, 2016 | -512.00M |
| September 30, 2016 | -1.219B |
| June 30, 2016 | -304.00M |
| March 31, 2016 | -372.90M |
| December 31, 2015 | -386.40M |
| September 30, 2015 | 51.70M |
| June 30, 2015 | -51.60M |
| March 31, 2015 | 98.50M |
| December 31, 2014 | 511.70M |
| September 30, 2014 | 276.40M |
| June 30, 2014 | 122.00M |
| March 31, 2014 | -20.30M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -4.843M |
| NervGen Pharma Corp. | 7.803M |
| Milestone Pharmaceuticals, Inc. | -28.61M |
| Appili Therapeutics, Inc. | -1.228M |
| Clearmind Medicine, Inc. | -0.9073M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.852B |
| Total Expenses (Quarterly) | 2.594B |
| EPS Diluted (Quarterly) | 0.6824 |
| Enterprise Value | 22.27B |
| Gross Profit Margin (Quarterly) | 65.04% |
| Profit Margin (Quarterly) | 9.12% |
| Earnings Yield | -46.15% |
| Operating Earnings Yield | 113.8% |
| Normalized Earnings Yield | 8.485 |